{"author_id": "1354214417790070788", "created_at": "2021-05-25T22:14:51.000Z", "text": "@ETFStockReport $SPY $DIA $OEF $QQQ $VIX $AAPL $MSFT $AMZN $GOOG $GOOGL $FB $TSLA $JPM $JNJ $WMT $UNH $NVDA $V $BRKB $MA $BAC $HD $PG $DIS $PYPL $CMCSA $XOM $ADBE $KO $VZ $INTC $ORCL $CSCO $NFLX $PFE $T $ABT $CRM $PEP $ABBV $CVX https://t.co/EYnz9QogtD", "id": "1397315251046174725"}
{"author_id": "1254035253104181256", "created_at": "2021-05-25T12:00:41.000Z", "text": "$ABBV AbbVie Receives European Commission Approval of VENCLYXTO\u00ae (venetoclax) in Combination with a Hypomethylating Agent for Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy\nhttps://t.co/jxI2SiIkUo", "id": "1397160693477089281"}
